2 Biotech Studs Under $10

Shares of Exelixis, Inc. (NASDAQ:EXEL) and Oncothyreon Inc (USA) (NASDAQ:ONTY) cost less than $10 -- and both have beaten the market

Sep 11, 2015 at 3:11 PM
facebook X logo linkedin


Since hitting a record high of $213.78 on May 20, the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) has lost roughly 8.5%. Nonetheless, a number of stocks have performed very well during the last three-plus months, including plenty of stocks trading under $10 per share. Among the top outperformers under $10 are Exelixis, Inc. (NASDAQ:EXEL) and Oncothyreon Inc (USA) (NASDAQ:ONTY) -- both of which, not coincidentally, belong to the red-hot healthcare sector.

EXEL is currently resting at $5.88, up 85% since its close on May 20 -- in large part due to a successful late-stage study of its kidney cancer drug cabozantinib, as well as a recent thumbs up from Swiss regulators on its melanoma treatment cobimetinib. In fact, the shares have more than quadrupled in value in 2015.

Additional upside could be on the way, if the FDA gives EXEL's cobimetinib a nod in November, or if short sellers begin to hit the exits. Nearly one-quarter of Exelixis, Inc.'s float is sold short, representing over seven days of pent-up buying demand, at typical volumes.

Meanwhile, ONTY has tacked on more than 36% since late May to trade at $3.30, boosted by well-received data at the American Society of Clinical Oncology's (ASCO) meeting in early June. Year-to-date, the shares have shot up nearly 74%, with the broad-market swoon in August contained by their 20-week moving average.

The brokerage bunch apparently likes what it's seen out of Oncothyreon Inc, with 80% of analysts doling out "buy" or better ratings -- with not a single "sell" in sight. However, short interest has been ramping up in recent reporting periods, and now represents 11% of the equity's total float -- a six-day short squeeze, at the stock's average pace of trading.
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI